ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein...

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• ZMPSTE24 is a human zinc metalloprotease essential for lamin A biogenesis.
• Defects in ZMPSTE24 function lead to progeroid syndromes like Hutchinson-Gilford progeria syndrome.
• Understanding ZMPSTE24's role in prelamin A processing is critical for disease research.

Purpose of the Study:

• To develop a humanized yeast system for assaying ZMPSTE24 activity.
• To investigate the impact of disease-associated ZMPSTE24 mutations on prelamin A processing.
• To explore potential therapeutic strategies for ZMPSTE24-related disorders.

Main Methods:

• Development of a 'humanized yeast system' to model ZMPSTE24 function.
• Assay of ZMPSTE24-dependent cleavage of prelamin A in yeast.
• Examination of eight known disease-associated ZMPSTE24 missense mutations.
• Analysis of ZMPSTE24 mutant rescue by Doa10 deletion or bortezomib treatment.

Main Results:

• All eight ZMPSTE24 mutations exhibited impaired prelamin A processing, categorized into activity, stability, or combined defects.
• Some ZMPSTE24 mutants were rescued by deleting the E3 ubiquitin ligase Doa10 or by proteasome inhibition with bortezomib.
• ZMPSTE24-mediated prelamin A cleavage was shown to be separable from its role in clearing translocon-clogged substrates.

Conclusions:

• The humanized yeast system provides a valuable tool for studying ZMPSTE24 function and disease mechanisms.
• The findings suggest potential therapeutic interventions for patients with ZMPSTE24-related progeroid syndromes.
• This research advances the understanding of membrane protein processing, stability, and disease.